Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2008

01-12-2008 | Epidemiology

Early radiation exposures and BRCA1-associated breast cancer in young women from Poland

Authors: Jacek Gronwald, Anouk Pijpe, Tomasz Byrski, Tomasz Huzarski, Małgorzata Stawicka, Cezary Cybulski, Flora van Leeuwen, Jan Lubiński, Steven A. Narod

Published in: Breast Cancer Research and Treatment | Issue 3/2008

Login to get access

Abstract

To study whether or not there is an adverse effect of early chest X-rays on breast cancer risk in breast cancer susceptibility gene 1 (BRCA1) carriers, we compared the histories of chest X-ray exposures before age 30 in 138 BRCA1 carriers with breast cancer with 158 age-matched women with breast cancer, but without a BRCA1 mutation. All cases were drawn from a national breast cancer research registry. Affected carriers reported more frequent chest X-ray use before age 20 than affected non-carriers (0.6 vs. 0.3; P = 0.01). Affected carriers had, on average, 1.8 chest X-rays before age 30 compared to an average of 1.0 for affected non-carriers (P = 0.002). The odds ratio for ever having had a chest X-ray below age 30, given a BRCA1 mutation, was 1.8 [95% confidence interval (CI) = 1.2–2.9; P = 0.01]. These observations support the hypothesis that early radiation exposure may be a risk factor for breast cancer in BRCA1 carriers.
Literature
1.
go back to reference Preston DL, Mattsson A, Holmberg E et al (2002) Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158:220–235PubMedCrossRef Preston DL, Mattsson A, Holmberg E et al (2002) Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158:220–235PubMedCrossRef
2.
go back to reference van Leeuwen FE, Klokman WJ, Stovall M et al (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst 95:971–980PubMedCrossRef van Leeuwen FE, Klokman WJ, Stovall M et al (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst 95:971–980PubMedCrossRef
3.
go back to reference Land CE, Tokunaga M, Koyama K et al (2003) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1990. Radiat Res 160:707–717PubMedCrossRef Land CE, Tokunaga M, Koyama K et al (2003) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1990. Radiat Res 160:707–717PubMedCrossRef
4.
go back to reference Hoffman DA, Lonstein JE, Morin MM et al (1989) Breast cancer in women with scoliosis exposed to multiple diagnostic X rays. J Natl Cancer Inst 81:1307–1312PubMedCrossRef Hoffman DA, Lonstein JE, Morin MM et al (1989) Breast cancer in women with scoliosis exposed to multiple diagnostic X rays. J Natl Cancer Inst 81:1307–1312PubMedCrossRef
5.
go back to reference Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182PubMedCrossRef Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182PubMedCrossRef
6.
go back to reference Lee JS, Collins KM, Brown AL et al (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404:201–204PubMedCrossRef Lee JS, Collins KM, Brown AL et al (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404:201–204PubMedCrossRef
7.
go back to reference Wu X, Ranganathan V, Weisman DS et al (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477–482PubMedCrossRef Wu X, Ranganathan V, Weisman DS et al (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477–482PubMedCrossRef
8.
go back to reference Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE); Gene Etude Prospective Sein Ovaire (GENEPSO); Gen en Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON) et al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. J Clin Oncol 24:3361–3366 Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE); Gene Etude Prospective Sein Ovaire (GENEPSO); Gen en Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON) et al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. J Clin Oncol 24:3361–3366
9.
go back to reference Lubinski J, Gorski B, Huzarski T et al (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71–76PubMedCrossRef Lubinski J, Gorski B, Huzarski T et al (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71–76PubMedCrossRef
10.
go back to reference Górski B, Jakubowska A, Huzarski T et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683–686PubMedCrossRef Górski B, Jakubowska A, Huzarski T et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683–686PubMedCrossRef
11.
go back to reference Narod SA, Lubinski J, Ghadirian P et al (2006) Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 7:402–406PubMedCrossRef Narod SA, Lubinski J, Ghadirian P et al (2006) Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 7:402–406PubMedCrossRef
12.
go back to reference Goldfrank D, Chuai S, Bernstein JL et al (2006) Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 15:2311–2313PubMedCrossRef Goldfrank D, Chuai S, Bernstein JL et al (2006) Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 15:2311–2313PubMedCrossRef
Metadata
Title
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland
Authors
Jacek Gronwald
Anouk Pijpe
Tomasz Byrski
Tomasz Huzarski
Małgorzata Stawicka
Cezary Cybulski
Flora van Leeuwen
Jan Lubiński
Steven A. Narod
Publication date
01-12-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-9892-9

Other articles of this Issue 3/2008

Breast Cancer Research and Treatment 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine